Business
Everything Electric London 2024 At Excel London
A Tesla Model 3 (Photo by John Keeble/Getty Images)
More Ads

Tesla said advertising was useless. Then sales slowed down.

One year after starting to run ads, Tesla has yet to figure out its advertising strategy.

Jack Raines

In May 2019, Elon Musk tweeted that Tesla “does not advertise or pay for endorsements. Instead, we use that money to make the product great.”

Four years later, at Tesla’s 2023 annual shareholder meeting, Musk changed his tune after acquiring Twitter, a company that makes money from selling ads.

"There's obviously a lot of people that follow the Tesla account and my account on Twitter — to some degree it is preaching to the choir and the choir is already convinced… we’ll try a little advertising and see how it goes,” Musk said, answering an audience question.

That advertising, it appears, has not gone well.

In March, Tesla started running ads on Musk’s newly acquired social media platform. Then, on April 22, Tesla fired its entire 40-person ad content team just four months after it launched, with Elon Musk commenting, “the ads were far too generic - could’ve been any car.” One day later, in what looks like an advertisement in all but name, American Idol judge Katy Perry tweeted a picture of her standing in front of a Cybertruck: “thx for delivery @ elonmusk.”

Why did Musk change his tune about advertising in the first place? Well, in 2019 when Musk was proudly anti-advertising, Tesla’s deliveries almost doubled from 63,000 in Q1 to 112,000 in Q4. However, growth has since slowed, with deliveries declining year over year by 8.5% in Q1 2024.

Advertising is an important growth strategy for automakers, especially in the US, where GM, Stellantis, Ford, and Toyota each spent more than $1 billion in 2022, so as sales slow for Tesla, it makes sense they would take ads for a test drive.

However, Tesla seems to be struggling to find its stride in advertising after 11 months, and the company advertising Musk’s cars on Musk's site feels redundant.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.